Stevan Aleksic

Stevan Aleksic, Ph.D., is a Senior Computational Drug Designer at Recursion since November 2024, following a tenure at Exscientia from February 2022 to November 2024 in the same role. Prior experience includes serving as a Postdoctoral Researcher in Computational Chemistry at Boehringer Ingelheim and as a Senior Scientist in Cheminformatics at Ryvu Therapeutics. Stevan's research involves biomolecular simulations, focusing on protein dynamics and multivalent ligand design. Educational qualifications comprise a Ph.D. in Theoretical Chemistry from Freie Universität Berlin, an MSc in Pharmaceutical Biotechnology from The Martin Luther University of Halle-Wittenberg, and a Diploma in Pharmacy from the University of Novi Sad. In addition, Stevan has held leadership positions in student organizations, including the Pharmaceutical Students’ Association of Novi Sad and the European Pharmaceutical Students' Association.